366
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome

, , , , , , , , , , , & show all
Pages 1371-1385 | Received 03 Jul 2014, Accepted 19 Aug 2014, Published online: 23 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Toshiyuki Matsunaga, Haruhi Saito, Satoshi Endo, Kazuhiro Iguchi, Midori Soda, Ossama El-Kabbani, Akira Hara & Akira Ikari. (2016) Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance. Free Radical Research 50:12, pages 1296-1308.
Read now

Articles from other publishers (26)

Jinping Lu, Ting Kang & Zhenlin Zhang. (2023) Diagnostic value of aldo‑keto reductase family 1 member B10 in human nasopharyngeal carcinoma. Molecular and Clinical Oncology 19:5.
Crossref
Abbas Salihi, Mohammed Al‑Naqshabandi, Zhikal Khudhur, Zjwan Housein, Harmand Hama, Ramyar Abdullah, Bashdar Hussen & Twana Alkasalias. (2022) Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review). Molecular Medicine Reports 26:1.
Crossref
Nang Lae Lae Phoo, Pornngarm Dejkriengkraikul, Patompong Khaw-On & Supachai Yodkeeree. (2021) Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death. International Journal of Molecular Sciences 22:22, pages 12512.
Crossref
Satoshi Endo, Toshiyuki Matsunaga & Toru Nishinaka. (2021) The Role of AKR1B10 in Physiology and Pathophysiology. Metabolites 11:6, pages 332.
Crossref
Yoshifumi Morikawa, Hidetoshi Miyazono, Yuji Sakai, Koichi Suenami, Yasuhide Sasajima, Kiyohito Sato, Yuji Takekoshi, Yasunari Monguchi, Akira Ikari & Toshiyuki Matsunaga. (2020) 4′-Fluoropyrrolidinononanophenone elicits neuronal cell apoptosis through elevating production of reactive oxygen and nitrogen species. Forensic Toxicology 39:1, pages 123-133.
Crossref
Sreeparna Banerjee. 2021. Cell Biology and Translational Medicine, Volume 14. Cell Biology and Translational Medicine, Volume 14 65 82 .
Lixia Fan, Ningze Zheng, Fuhua Peng, Ziyu Zhao, Di Fan, Shaoyi Cai, Liang Tao & Qin Wang. (2020) Nitric oxide affects cisplatin cytotoxicity oppositely in A2780 and A2780‐CDDP cells via the connexin32/gap junction. Cancer Science 111:8, pages 2779-2788.
Crossref
Albert W. Girotti. (2019) Nitric Oxide‐Mediated Resistance to Antitumor Photodynamic Therapy. Photochemistry and Photobiology 96:3, pages 500-505.
Crossref
Jared M. Newton, Aurelie Hanoteau, Hsuan-Chen Liu, Angelina Gaspero, Falguni Parikh, Robyn D. Gartrell-Corrado, Thomas D. Hart, Damya Laoui, Jo A. Van Ginderachter, Neeraja Dharmaraj, William C. Spanos, Yvonne Saenger, Simon Young & Andrew G. Sikora. (2019) Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Aurelie Hanoteau, Jared M. Newton, Rosemarie Krupar, Chen Huang, Hsuan-Chen Liu, Angelina Gaspero, Robyn D. Gartrell, Yvonne M. Saenger, Thomas D. Hart, Saskia J. Santegoets, Damya Laoui, Chad Spanos, Falguni Parikh, Padmini Jayaraman, Bing Zhang, Sjoerd H. Van der Burg, Jo A. Van Ginderachter, Cornelis J. M. Melief & Andrew G. Sikora. (2019) Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Satoshi Endo, Mai Uchibori, Miho Suyama, Mei Fujita, Yuki Arai, Dawei Hu, Shuang Xia, Biao Ma, Aurangazeb Kabir, Yuji O. Kamatari, Kazuo Kuwata, Naoki Toyooka, Toshiyuki Matsunaga & Akira Ikari. (2019) Novel Atg4B inhibitors potentiate cisplatin therapy in lung cancer cells through blockade of autophagy. Computational Toxicology 12, pages 100095.
Crossref
Ming Zhan, Hui Wang, Sun-Wang Xu, Lin-Hua Yang, Wei Chen, Shuang-Xia Zhao, Hui Shen, Qiang Liu, Rui-Meng Yang & Jian Wang. (2019) Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer. EBioMedicine 48, pages 143-160.
Crossref
Chih‐Yeu Fang, Yun‐Ho Lin & Chi‐Long Chen. (2019) Overexpression of AKR1B10 predicts tumor recurrence and short survival in oral squamous cell carcinoma patients. Journal of Oral Pathology & Medicine 48:8, pages 712-719.
Crossref
Toshiyuki Matsunaga, Saeka Tsuchimura, Nozomi Azuma, Satoshi Endo, Kenji Ichihara & Akira Ikari. (2019) Caffeic acid phenethyl ester potentiates gastric cancer cell sensitivity to doxorubicin and cisplatin by decreasing proteasome function. Anti-Cancer Drugs 30:3, pages 251-259.
Crossref
Jonathan Fahey & Albert Girotti. (2019) Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation. Cancers 11:2, pages 231.
Crossref
Qingbin Cui, Yuqi Yang, Ning Ji, Jing-Quan Wang, Liang Ren, Dong-Hua Yang & Zhe-Sheng Chen. (2019) Gaseous signaling molecules and their application in resistant cancer treatment: from invisible to visible. Future Medicinal Chemistry 11:4, pages 323-336.
Crossref
Arnatchai Maiuthed, Narumol Bhummaphan, Sudjit Luanpitpong, Apiwat Mutirangura, Chatchawit Aporntewan, Arthitaya Meeprasert, Thanyada Rungrotmongkol, Yon Rojanasakul & Pithi Chanvorachote. (2018) Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation. Journal of Biological Chemistry 293:35, pages 13534-13552.
Crossref
Jonathan M. Fahey, Jennifer S. Stancill, Brian C. Smith & Albert W. Girotti. (2018) Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1. Journal of Biological Chemistry 293:14, pages 5345-5359.
Crossref
Leonardo Vinícius Monteiro de Assis, Maria Nathalia Moraes, Keila Karoline Magalhães-Marques & Ana Maria de Lauro Castrucci. (2018) Melanopsin and rhodopsin mediate UVA-induced immediate pigment darkening: Unravelling the photosensitive system of the skin. European Journal of Cell Biology 97:3, pages 150-162.
Crossref
Satoshi Endo, Shuang Xia, Miho Suyama, Yoshifumi Morikawa, Hiroaki Oguri, Dawei Hu, Yoshinori Ao, Satoyuki Takahara, Yoshikazu Horino, Yoshihiro Hayakawa, Yurie Watanabe, Hiroaki Gouda, Akira Hara, Kazuo Kuwata, Naoki Toyooka, Toshiyuki Matsunaga & Akira Ikari. (2017) Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells. Journal of Medicinal Chemistry 60:20, pages 8441-8455.
Crossref
Akira Hara, Satoshi Endo, Toshiyuki Matsunaga, Ossama El-Kabbani, Takeshi Miura, Toru Nishinaka & Tomoyuki Terada. (2017) Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs. Biochemical Pharmacology 138, pages 185-192.
Crossref
Hui-Hsin Ko, Shih-Lung Cheng, Jang-Jaer Lee, Hsin-Ming Chen, Mark Yen-Ping Kuo & Shih-Jung Cheng. (2017) Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma. Head & Neck 39:7, pages 1327-1332.
Crossref
Akira Hara, Satoshi Endo, Toshiyuki Matsunaga, Midori Soda, Ossama El-Kabbani & Koji Yashiro. (2016) Inhibition of aldo-keto reductase family 1 member B10 by unsaturated fatty acids. Archives of Biochemistry and Biophysics 609, pages 69-76.
Crossref
Albert Girotti. (2016) Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide. Cancers 8:10, pages 96.
Crossref
Toshiyuki Matsunaga, Ayaka Suzuki, Chihiro Kezuka, Naoko Okumura, Kazuhiro Iguchi, Ikuo Inoue, Midori Soda, Satoshi Endo, Ossama El-Kabbani, Akira Hara & Akira Ikari. (2016) Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism. Chemico-Biological Interactions 256, pages 142-153.
Crossref
Yoshifumi Morikawa, Chihiro Kezuka, Satoshi Endo, Akira Ikari, Midori Soda, Keiko Yamamura, Naoki Toyooka, Ossama El-Kabbani, Akira Hara & Toshiyuki Matsunaga. (2015) Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo–keto reductase 1B10. Chemico-Biological Interactions 230, pages 30-39.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.